Trench Fever That Affected Tolkien, C.S. Lewis Could Be Prevented: Scientists
The discovery of a special antibody could help prevent dangerous bacterial infections such as trench fever, which is transmitted by body lice.
Stay updated with breaking news from Daniel Pinschewer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The discovery of a special antibody could help prevent dangerous bacterial infections such as trench fever, which is transmitted by body lice.
Viruses do not always kill the cells they infect. Researchers at the University of Basel have discovered in experiments with mice that cells have the power to self-heal and eliminate viruses. However, these cells undergo long-term changes.
E-Mail Immune cells specialize to ensure the most efficient defense against viruses and other pathogens. Researchers at the University of Basel have shed light on this specialization of T cells and shown that it occurs differently in the context of an acute and a chronic infection. This could be relevant for new approaches against chronic viral infections. Researchers led by Professor Carolyn King of the University of Basel have developed a method to study the specialization of T cells in the context of infections. In the journal eLife, they report the different directions this specializat...
Using two different viruses to tackle tumors An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines. Using two different viruses as vehicles, they administered specific tumor components in experiments on mice with cancer in order to stimulate their immune system to attack the tumor. The approach is now being tested in clinical studies. Making use of the immune system as an ally in the fight against cancer forms the basis of a wide range of modern cancer therapies. One of these is therapeutic cancer vaccination: followi...
An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines. Using two different viruses as vehicles, they administered specific tumor components in experiments on mice with cancer in order to stimulate their immune system to attack the tumor. The approach is now being tested in clinical studies.